Menu

Back to Medication Guide

Sucralfate

Generic Name: Sucralfate

Brand Names: Carafate

Sucralfate is a mucosal protectant that forms a protective barrier over ulcers to promote healing.

Gastrointestinal

Drug Class

GI Mucosal Protectant (Cytoprotective Agent)

Pregnancy

Category B — No evidence of fetal harm in animal studies; limited human data

Available Forms

1 g oral tablet, 1 g/10 mL oral suspension

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseTypical Maintenance Dose
Active duodenal ulcer (treatment)1 g four times daily (1 hour before meals and at bedtime)1 g four times daily for 4–8 weeks
Duodenal ulcer (maintenance / prevention of recurrence)1 g twice daily1 g twice daily
Stress ulcer prophylaxis (off-label, ICU)1 g every 6 hours via NG tube or oral1 g every 6 hours

Side Effects

Common Side Effects:

  • Constipation (most common)
  • Dry mouth
  • Nausea
  • Stomach discomfort
  • Diarrhea
  • Headache
  • Dizziness

Serious Side Effects:

  • Aluminum toxicity (in renal impairment)
  • Bezoar formation
  • Hypersensitivity reactions (rare)

Drug Interactions

Major Drug & Food Interactions

  • Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, moxifloxacin): Sucralfate drastically reduces fluoroquinolone absorption (by up to 90%); take fluoroquinolones at least 2 hours before sucralfate.
  • Phenytoin: Sucralfate reduces phenytoin absorption; separate dosing by at least 2 hours and monitor phenytoin levels.
  • Tetracycline antibiotics (doxycycline, tetracycline): Significantly reduced absorption; separate by at least 2 hours.
  • Levothyroxine: Sucralfate can bind thyroid hormone in the GI tract, reducing absorption; take levothyroxine at least 4 hours before sucralfate.
  • Warfarin: May reduce warfarin absorption in some patients; monitor INR when starting or stopping sucralfate.
  • Antacids (aluminum/magnesium): Taking antacids within 30 minutes before or after sucralfate may reduce sucralfate's ability to bind to the ulcer site; separate by at least 30 minutes.

Additional Information

Sucralfate is a unique gastrointestinal medication that forms a protective barrier over ulcerated mucosa. It is used to treat and prevent duodenal ulcers and maintain healed ulcers, working through local cytoprotective mechanisms rather than acid suppression.

Mechanism of Action

Sucralfate provides mucosal protection through multiple mechanisms:

  • Barrier formation: In acidic environment, forms a viscous, adhesive paste that binds to ulcer base
  • Selective binding: Adheres to ulcerated tissue with higher affinity than normal mucosa
  • Protects from acid and pepsin: Physical barrier prevents further damage
  • Stimulates prostaglandin synthesis: Enhances mucosal defense
  • Binds bile salts: Reduces mucosal injury from refluxed bile
  • Promotes growth factor binding: Concentrates EGF and FGF at ulcer site

Sucralfate is a complex of sulfated sucrose and aluminum hydroxide.

Available Formulations

Sucralfate is available as:

  • Tablets: 1 g
  • Oral suspension: 1 g/10 mL

Medical Uses

FDA-Approved Indications:

  • Short-term treatment (up to 8 weeks) of active duodenal ulcer
  • Maintenance therapy of healed duodenal ulcer

Off-Label Uses:

  • Stress ulcer prophylaxis in critically ill patients
  • GERD
  • Radiation-induced esophagitis or proctitis
  • Mucositis
  • Gastric ulcers

Dosing Guidelines

Active Duodenal Ulcer:

  • 1 g four times daily on an empty stomach (1 hour before meals and at bedtime)
  • Treatment duration: 4-8 weeks

Maintenance Therapy:

  • 1 g twice daily on an empty stomach

Administration:

  • Take on empty stomach for optimal efficacy
  • Do not crush or chew tablets
  • Shake suspension well before use

Important Safety Information

Contraindications:

  • Known hypersensitivity to sucralfate or any component

Warnings and Precautions:

  • Aluminum toxicity: Use with caution in chronic renal failure (aluminum accumulation)
  • Bezoar formation: Cases reported, especially in critically ill patients with tube feeding
  • Duodenal ulcer is a chronic disease: Successful healing requires follow-up
  • Drug binding: May interfere with absorption of many medications

Drug Interactions

Sucralfate can bind to and reduce absorption of many drugs. Separate administration by at least 2 hours:

  • Fluoroquinolones (ciprofloxacin, levofloxacin): Significantly reduced absorption
  • Tetracyclines: Reduced absorption
  • Phenytoin: Reduced absorption
  • Warfarin: May reduce absorption
  • Digoxin: May reduce absorption
  • Ketoconazole: May reduce absorption
  • Levothyroxine: May reduce absorption
  • Quinidine: Reduced serum levels

Antacids: May interfere with sucralfate binding; separate by 30 minutes

Special Populations

  • Renal Impairment: Use with caution due to aluminum absorption risk; avoid in severe/dialysis patients if possible
  • Hepatic Impairment: No specific adjustment
  • Pregnancy: Limited data; use only if clearly needed
  • Lactation: Unknown if excreted in milk; likely minimal absorption
  • Elderly: Consider renal function; monitor for aluminum toxicity in long-term use
  • Pediatric: Safety and efficacy not established

Frequently Asked Questions

Unlike PPIs or H2 blockers, sucralfate does not reduce stomach acid production. Instead, in the acidic environment of the stomach (pH < 4), sucralfate forms a thick, paste-like complex that adheres directly to the ulcer crater, creating a physical protective barrier. This shield protects the exposed tissue from further acid, pepsin, and bile salt damage while the ulcer heals underneath.
Sucralfate must be taken 1 hour before meals because it needs to bind to the ulcer site before food arrives. Food can interfere with the medication's ability to form its protective barrier, and certain food components may bind to sucralfate and reduce its effectiveness. Taking it before meals ensures it has time to adhere to the ulcer.
Yes. Constipation is the most commonly reported side effect, occurring in about 2% of patients. Sucralfate contains aluminum, which is astringent and can contribute to constipation. Maintaining adequate fiber intake and hydration can help. If constipation becomes severe, discuss alternatives with your doctor.
Sucralfate can bind to many medications in the GI tract, reducing their absorption. This is particularly problematic for antibiotics (fluoroquinolones, tetracyclines), phenytoin, levothyroxine, and warfarin. As a general rule, take other medications at least 2 hours before or after sucralfate to avoid interactions.
For patients with normal kidney function, aluminum absorption from sucralfate is minimal and not a significant concern. However, patients with chronic kidney disease or dialysis patients are at risk for aluminum accumulation, which can cause bone disease, encephalopathy, and anemia. These patients should avoid long-term sucralfate use.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

  • How should I time my other medications around sucralfate to avoid absorption problems?
  • Is sucralfate or a proton pump inhibitor a better option for my condition?
  • Given my kidney function, is long-term sucralfate safe for me?
  • Should I also be tested for H. pylori as the underlying cause of my ulcer?

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Questions About This Medication?

Talk to your doctor or pharmacist about whether Sucralfate is right for you.

Contact Us

Call: (727) 820-7800